Sebia acquires Zeus Scientific
Acquisition11/10/2022
Sebia announced its acquisition of Zeus Scientific, a New Jersey diagnostics company specializing in autoimmune and infectious-disease testing. The acquisition expanded Sebia’s product portfolio and United States presence. Financial terms were undisclosed. The company’s current history also records the 2022 acquisition.
Type
Acquisition
Announced
11/10/2022
Amount
Financial data requires access
Reported parties
Sebia; Zeus Scientific